Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 46 (10%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 376 (84%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (18%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAPROXEN EC | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2018-07-25 | 2018-12-11 | 56416 |
| NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2018-05-16 | 2018-08-16 | 49537 |
| DICLOFENAC EC | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2017-04-10 | 2017-04-27 | 6274 |
| DICLOFENAC EC | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2019-03-16 | 2024-03-02 | 78849 |
| RABEPRAZOLE EC | 10MG | TABLET (ENTERIC-COATED) | Actual shortage | 2023-12-26 | 2024-05-08 | 214284 |
| RABEPRAZOLE EC | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2023-07-18 | 2023-12-01 | 198918 |
| RABEPRAZOLE EC | 20MG | TABLET (ENTERIC-COATED) | Actual shortage | 2024-01-17 | 2024-01-30 | 216283 |
| RABEPRAZOLE EC | 20MG | TABLET (ENTERIC-COATED) | Actual shortage | 2024-04-10 | 2024-04-11 | 224797 |
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Resolved | 2017-08-02 | 2020-02-27 | 17955 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2017-08-02 | 2020-02-27 | 17958 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2017-08-02 | 2020-02-27 | 17961 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-29 | 2020-06-03 | 100024 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-29 | 2024-03-02 | 100028 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-29 | 2024-03-02 | 100031 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-22 | 2020-02-07 | 99541 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-02-19 | 2020-03-24 | 106721 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-03-26 | 2020-04-08 | 109432 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-12 | 2024-03-02 | 144044 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-12 | 2024-03-02 | 144047 |
| TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-11-22 | 2024-04-05 | 211102 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |